Journal:
:nanomedicine journal
0
heydar mohammady novel drug delivery systems lab, faculty of pharmacy, tehran university of medical sciences, tehran, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (tehran university of medical sciences)
rassoul dinarvand novel drug delivery systems lab, faculty of pharmacy, tehran university of medical sciences, tehran, iran
medical nanotechnology research center, faculty of pharmacy, tehran university of medical sciences, tehran , iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (tehran university of medical sciences)
mehdi esfandyari manesh novel drug delivery systems lab, faculty of pharmacy, tehran university of medical sciences, tehran, iran
medical nanotechnology research center, faculty of pharmacy, tehran university of medical sciences, tehran , iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (tehran university of medical sciences)
pedram ebrahimnejad department of pharmaceutics, faculty of pharmacy, mazandaran university of medical sciences, sari, iran
objective(s): irinotecan is a potent anti-cancer drug from camptothecin group which inhibits topoisomerase i. recently, biodegradable and biocompatible polymers such as poly lactide-co-glycolides (plga) have been considered for the preparation of nanoparticles (nps). materials and methods: in this study, irinotecan loaded plga nps were fabricated by an emulsification/solvent diffusion method to...